LM N°1/ 2024. GOOD PRACTICES FOR THE PREPARATION OF AUTOLOGOUS PLATELET-RICH PLASMA (PRP-A) FROM THE RECIPIENT'S OWN BLOOD. Daphné V. DIERMAN, PhD Pharmacist, Antoine TURZI, CEO RegenLab.
New cell therapies characterized as autologous (organic substance from which the donor and
the recipient is the same individual) are found on the market, their preparations are dependent on
the use of medical devices certified by an accredited organization, enabling them to minimize
risks of contamination (infection), standardize the steps in a closed circuit and demonstrate the efficiency of the process.
therapeutic.
We will discuss the preparation of biological products derived from human blood for therapeutic purposes.
and specifically the preparation of autologous platelet-rich plasma (PRP-A).
LM N°1/ 2024. THE CELLULAR MATRIX® REVOLUTION IN THE TREATMENT OF GONARTHROSIS: FROM AH VISCOSUPPLEMENTATION TO COMBINATION WITH PRP. Philippe ADAM MD, Marine DELCROS, MD - RegenLab
THE CELLULAR MATRIX® REVOLUTION IN THE TREATMENT OF GONARTHROSIS: FROM VISCOSUPPLEMENTATION WITH AH TO COMBINATION WITH PRP. THE CELLULAR MATRIX® REVOLUTION IN THE TREATMENT OF GONARTHROSE: FROM VISCOSUPPLEMENTATION WITH HA TO ASSOCIATION WITH PRP Philippe ADAM MD, radiologist at Clinique Médipôle Garonne, Toulouse. Marine DELCROS [...]
LM N°1/ 2024. OVERVIEW OF REGENLAB'S PATENTED TECHNOLOGIES. Andreas PIGNI. Legal Affairs, RegenLab SA.
OVERVIEW OF REGENLAB'S PATENTED TECHNOLOGIES Andreas PIGNI Legal Affairs, RegenLab SA INTRODUCTION RegenLab SA has established itself as a pioneer and leader in regenerative medicine, known for its innovative technologies that synergistically use platelet-rich plasma (PRP) in combination with various bioactive/therapeutic agents, thus providing solutions to [...].
LM N°1/ 2024. Autologous PRP or "The Fairy Plate" in the magical land of regenerative autologous cellular medicine. Antoine TURZI. CEO of RegenLab
Platelet Rich Plasma (PRP) has emerged as an innovative therapeutic modality in a variety of medical fields, offering promising prospects for wound healing, facial rejuvenation and even genital rejuvenation.
Our clinical research is resolutely committed to studying these applications, seeking to determine the efficacy and safety of RegenPRP® (standardized PRP prepared with technology from RegenLab SA, Switzerland) in these varied clinical contexts.
LM N°2 / 2023. Theme 3. Clinical research in regenerative medicine with REGENLAB. Evaluation of alpha-2-macroglobulin and extracellular vesicles in RegenLab platelet-rich plasma.
Clinical research in regenerative medicine with REGENLAB. Evaluation of alpha-2-macroglobulin and extracellular vesicles in RegenLab platelet-rich plasma Daniel A. GRANDE, Michael R. TUCKER, Andrew R. SAMUEL, Antoine TURZI. TUCKER, Andrew R. SAMUEL, Antoine TURZI 1. Pr Daniel A. Grande, MD. Professor, Molecular Medicine and Orthopedic Surgery, Feinstein Institutes for Medical Research at Hofstra/Northwell (USA). [...]
LM N°1 / 2023. REGEN LAB, LONG ISLAND UNIVERSITY (LIU) AND DASSAULT SYSTEMES, A PARTNERSHIP FOR THE DEVELOPMENT OF REGENERATIVE MEDICINE.
Aesthetic health news. New York, May 03, 2023 Regen Lab, Long Island University (LIU) and Dassault Systèmes celebrated a partnership rich in potential for the development of regenerative medicine research. Regen Lab is a leading industrial innovator of medical devices in the U.S. and [...].
LM N°1 / 2023. Neck aesthetics with PRP & AH Cellular Matrix® from REGEN LAB. Clinical case of SUTHA Aesthetics (London)
Clinic: Neck aesthetics with Regen Lab's PRP & AH Cellular Matrix® regenerative medicine WHAT IS PRP & HA? Sutha Aesthetics is proud to offer you the evolution of PRP (Platelet-Rich Plasma) with the added boost of HA (hyaluronic acid). PRP is a well-known healer and sealer (not a filler) that regenerates tissues [...].
LM N°1 / 2023. IN NEW YORK, MAY 03, 2023 REGEN LAB, LONG ISLAND UNIVERSITY (LIU) AND DASSAULT SYSTEMES CELEBRATED A PARTNERSHIP RICH IN POTENTIAL FOR THE DEVELOPMENT OF REGENERATIVE MEDICINE RESEARCH.
Editorial "RegenLab, Long Island University, Dassault Systèmes commit to the development of regenerative medicine research." Regen Lab is a company dedicated to applied research in the fields of cell and tissue biostimulation for over 20 years, which has developed in Switzerland with remarkable success in the use of PRP [...].
LM N°1 / 2023. NEWS. MODERN CELL THERAPY AND TISSUE ENGINEERING TURN 20! "WELCOME TO REGENERATIVE MEDICINE". Antoine TURZI, CEO of REGENLAB
Editorial Welcome to regenerative medicine. Cell therapies and tissue engineering are 20 years old! Antoine Turzi CEO of REGENLAB I/ Welcome to the world of regenerative medicine research Some 50 years ago, Prof. Joseph Vacanti (John Homans Professor of Surgery, Massachusetts General Hospital, USA) taught the world [...].
